title: Achievement of morphologic and cytogenetic remission with single-agent hydroxyurea in a patient with acute myeloid leukemia with inv(16).
authors.affiliation: Department of Medicine.
authors.forename: Ami B
authors.initials: AB
authors.lastname: Patel
authors.forename: Yi-Hua
authors.initials: YH
authors.lastname: Chen
authors.forename: Yanming
authors.initials: Y
authors.lastname: Zhang
authors.forename: Olga
authors.initials: O
authors.lastname: Frankfurt
authors.forename: Jane N
authors.initials: JN
authors.lastname: Winter
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000627:therapeutic use; D007446:Chromosome Inversion; D050658:Core Binding Factor beta Subunit / Q000235:genetics; D023061:Gene Order; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use*; D017404:In Situ Hybridization, Fluorescence; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D012074:Remission Induction; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; C493692:CBFB protein, human; D050658:Core Binding Factor beta Subunit; D006918:Hydroxyurea